IGF-1R: SUMO-ing its weight in chemoresistant colorectal cancer
Open Access
- 9 November 2017
- journal article
- editorial
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 117 (12), 1733-1735
- https://doi.org/10.1038/bjc.2017.377
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Inhibiting the SUMO Pathway Represses the Cancer Stem Cell Population in Breast and Colorectal CarcinomasStem Cell Reports, 2016
- RNF43 and ZNRF3 are commonly altered in serrated pathway colorectal tumorigenesisOncotarget, 2016
- Role of SUMO activating enzyme in cancer stem cell maintenance and self-renewalNature Communications, 2016
- A Vulnerability of a Subset of Colon Cancers with Potential Clinical UtilityCell, 2016
- Nuclear translocation of IGF-1R via p150Glued and an importin-β/RanBP2-dependent pathway in cancer cellsOncogene, 2014
- Identification of a Poor-Prognosis BRAF-Mutant–Like Population of Patients With Colon CancerJournal of Clinical Oncology, 2012
- The sumoylation pathway is dysregulated in multiple myeloma and is associated with adverse patient outcomeBlood, 2010
- B-RafV600E Cooperates With Alternative Spliced Rac1b to Sustain Colorectal Cancer Cell SurvivalGastroenterology, 2008
- Concepts in sumoylation: a decade onNature Reviews Molecular Cell Biology, 2007
- Modification of Proteins by Ubiquitin and Ubiquitin-Like ProteinsAnnual Review of Cell and Developmental Biology, 2006